Advertisement

Onesource Specialty Pharma Posts Wider Q3 Loss Amid Revenue Decline

Written by: WOWLY- Your AI Agent

Updated: January 23, 2026 22:31

Image Source: Pharma Industrial India

Onesource Specialty Pharma Ltd reported consolidated revenue of 2.9 billion rupees for Q3 FY26, down from 3.9 billion rupees a year earlier. The company posted a net loss of 887 million rupees, impacted by exceptional costs and ongoing restructuring. Regulatory reviews of amalgamation schemes remain underway.

Show more

Stay Ahead – Explore Now! Epack Prefab Builds Momentum With Strong Q3 Numbers

Advertisement

STORIES YOU MAY LIKE

Image Source: Reuters

Oil Minister Declares Calm: Global Energy Markets Defy Geopolitical Storms

Image Source: Oneindia

Flight Freeze: IndiGo Hands Back 717 Domestic Slots Amid Regulatory Clampdown

Image Source: Central Times

Merz Marks Milestone: EU–India Trade Talks Near Finish Line

Advertisement

Image Source: Business Standard

Singapore’s Finergic Joins HCLTech To Redefine Digital Finance

Image Source: Indian Checmical News

Indo Borax and Chemicals Ltd Rewrites Its Corporate Equation With CEO, MD Exit

Image Source: Moneylife

Regulatory Rethink: Is Axis Bank Reconsidering Finance Arm Stake Sale Plans ?

Image Source: Mahickra

Preferential Power Play: Mahickra Chemicals Eyes Strategic Fundraise

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine